Notch and cancer: a double-edged sword

被引:0
|
作者
U. Koch
F. Radtke
机构
[1] Ecole Polytechnique Fédérale de Lausanne (EPFL),The Swiss Institute for Experimental Cancer Research (ISREC)
来源
关键词
Notch signaling; oncogene; tumor suppressor; cancer; therapy;
D O I
暂无
中图分类号
学科分类号
摘要
The highly conserved Notch signaling pathway plays pleiotropic roles during embryonic development and is important for the regulation of selfrenewing tissues. The physiological functions of this signaling cascade range from stem cell maintenance and influencing cell fate decisions of barely differentiated progenitor cells, to the induction of terminal differentiation processes, all of which have been found to be recapitulated in different forms of cancers. Although Notch signaling has mostly been associated with oncogenic and growth-promoting roles, depending on the tissue type it can also function as a tumor suppressor. Here we describe recent findings on Notch signaling in cancer and tumor angiogenesis, and highlight some of the therapeutic approaches that are currently being developed to interfere with tumor growth and progression.
引用
收藏
页码:2746 / 2762
页数:16
相关论文
共 50 条
  • [41] Chemotherapy: a double-edged sword in cancer treatment
    Nafiseh Behranvand
    Farzad Nasri
    Reza Zolfaghari Emameh
    Pouria Khani
    Asieh Hosseini
    Johan Garssen
    Reza Falak
    Cancer Immunology, Immunotherapy, 2022, 71 : 507 - 526
  • [42] Immune system: a double-edged sword in cancer
    Bodduluru Lakshmi Narendra
    Kasala Eshvendar Reddy
    Saladi Shantikumar
    Sistla Ramakrishna
    Inflammation Research, 2013, 62 : 823 - 834
  • [43] Mast cells: A double-edged sword in cancer
    Derakhshani, Afshin
    Vahidian, Fatemeh
    Alihasanzadeh, Mohammad
    Mokhtarzadeh, Ahad
    Nezhad, Parisa Lotfi
    Baradaran, Behzad
    IMMUNOLOGY LETTERS, 2019, 209 : 28 - 35
  • [44] Exosomes: a double-edged sword in cancer immunotherapy
    Chen, Jiayi
    Hu, Siyuan
    Liu, Jiayi
    Jiang, Hao
    Wang, Simiao
    Yang, Zhaogang
    MEDCOMM, 2025, 6 (03):
  • [45] Chemotherapy: a double-edged sword in cancer treatment
    Behranvand, Nafiseh
    Nasri, Farzad
    Emmameh, Zolfaghari
    Khani, Pouria
    Hosseini, Asieh
    Garssen, Johan
    Falak, Reza
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 507 - 526
  • [46] The role of necroptosis in cancer: A double-edged sword?
    Qin, Xia
    Ma, Dan
    Tan, Ye-xiong
    Wang, Hong-yang
    Cai, Zhenyu
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (02): : 259 - 266
  • [47] Hypoxia: A Double-Edged Sword in Cancer Therapy
    Khoshinani, Hamed Manoochehri
    Afshar, Saeid
    Najafi, Rezvan
    CANCER INVESTIGATION, 2016, 34 (10) : 536 - 545
  • [48] Antibiotics for cancer treatment: A double-edged sword
    Gao, Yuan
    Shang, Qingyao
    Li, Wenyu
    Guo, Wenxuan
    Stojadinovic, Alexander
    Mannion, Ciaran
    Man, Yan-gao
    Chen, Tingtao
    JOURNAL OF CANCER, 2020, 11 (17): : 5135 - 5149
  • [49] Akt: a double-edged sword
    Meera Swami
    Nature Reviews Cancer, 2009, 9 : 76 - 77
  • [50] Ferroptosis: A double-edged sword
    Wang, Shengmei
    Guo, Qiuyan
    Zhou, Lili
    Xia, Xinhua
    CELL DEATH DISCOVERY, 2024, 10 (01)